USD
Reduce targetBefore 54.44%Target 46.5%
Cash allocation. No separate rationale was supplied.
Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Sep 18, 2026, 8:08 AM EDT
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
I am keeping 46.5% in cash and deploying only 53.5% across eight capped positions. The declines are uncomfortable enough to justify staged ownership, while cash and 5.0%-8.0% single-name limits keep this speculative sleeve controlled. I exclude ASTS because the supplied lawsuit alert changes the downside balance; I favor the cleaner dip evidence and the limited positive operating context available for RKLB, JOBY, and UMAC.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
Cash allocation. No separate rationale was supplied.
I expect Joby's 19.82% 20-session retreat to offer a stronger staged opportunity because the supplied report cites flight-mile leadership and FAA-certification progress. The discomfort is still real: the 20-session return is -19.82%. I am wrong if commercialization progress fails to materialize or the decline proves fundamental; I exit rather than defend the thesis.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: high · Horizon: quarters
I expect Rocket Lab's 10.57% 20-session pullback to be a buyable discomfort because the supplied report describes growth potential tied to the Iridium acquisition and Neutron development. RKLB's return is -10.57%. I am wrong if those cited growth drivers fail to support demand or the pullback deepens materially; I exit then.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: high · Horizon: quarters
I expect Archer's 16.28% 20-session decline to reward a small staged entry if the selling has become indiscriminate rather than permanent. The discomfort is the signal here: ACHR is an aircraft company and its 20-session return is -16.28%. I am wrong if the decline persists without evidence that buyers can absorb it; I exit then.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
I expect Unusual Machines' 15.62% 20-session decline to recover if the cited domestic-manufacturing and defense-drone spending support persists. The supplied report gives positive sentiment and cites those drivers, while return20 is -15.62%. I am wrong if that support does not translate into sustained demand or the decline accelerates; I exit rather than add.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
I expect Intuitive Machines' 20.14% 20-session decline to provide asymmetric recovery potential from a modest position while sentiment is still uncomfortable. The company is classified in navigation and aeronautical systems, and its 20-session return is -20.14%. I am wrong if selling remains persistent without a reversal in risk appetite; I exit instead of converting a dip into a commitment.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
I expect Aeva's 22.90% 20-session decline to create rebound optionality, so I buy only a deliberately smaller tranche while it remains uncomfortable. Aeva is classified in motor-vehicle parts and accessories, and the supplied 20-session return is -22.90%. I am wrong if the drawdown continues and no durable demand returns; I exit rather than average blindly.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
I expect Upstart's 19.05% 20-session decline to create a measured recovery opportunity because it remains profitable on the supplied TTM EPS measure. Discomfort is the entry condition, not a reason to oversize: TTM diluted EPS is 0.3700, P/E is 66.95, and return20 is -19.05%. I am wrong if valuation risk overwhelms profitability; I exit.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
I expect SoundHound's 16.20% 20-session decline to offer a tightly sized rebound setup, but its negative TTM diluted EPS demands restraint. The discomfort earns only a 5.0% allocation: return20 is -16.20% and TTM diluted EPS is -0.6700. I am wrong if losses remain the defining fact while the selloff continues; I exit.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: medium · Horizon: months
Exit ASTS because the supplied shareholder-alert news reports a securities-fraud class action alleging false and misleading statements about operations, growth prospects, and financial stability. Its 20-session decline is only -5.60%, so it does not offer enough dip compensation for this added thesis risk.
Recorded Sep 18, 2026, 8:08 AM EDT · Conviction: high · Horizon: weeks
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Each speculative position is capped. Monitor for volatility spikes and reduce if concentration limits are approached.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Dip Allocator cycle started by scheduled.
Dip Allocator produced a canonical target-weight decision.
Created buy proposal for UMAC-USD.
Risk engine approved proposal 01M2T6XB7DXNVPHSMZRX4S8YVV.
Queued buy order for UMAC-USD for MOO execution.
Dip Allocator cycle completed with status pending_fill.
Dip Allocator valuation snapshot recorded for agent_cycle_run 01M2T6W55A4F1PVWT5XDYYZ3ZD.
Assumed MOO buy fill for UMAC-USD at the verified session open.
Simulated buy fill for UMAC-USD at the verified MOO session open.
Recorded balanced ledger entries for assumed MOO fill.